This genomic analysis highlights the biocontrol properties of Bacillus amyloliquefaciens LJ1 in preventing post-harvest rot in Nanguo pears, suggesting sustainable agricultural applications.
Bacillus amyloliquefaciens is a well-recognized biocontrol agent and plant growth promoter. This study characterized the endophytic B. amyloliquefaciens LJ1, isolated from Nanguo pear fruit, through whole-genome sequencing and functional analyses. The B. amyloliquefaciens LJ1 genome (3,947,365 bp, 46.48% GC content) encodes 3757 protein-coding sequences. Genomic analysis revealed diverse carbohydrate-active enzymes (CAZymes) and 12 secondary metabolite biosynthetic gene clusters, including those potentially producing surfactin, fengycin, bacillibactin, and bacilysin. Safety assessments, including hemolysis, indole production, biogenic amine production, and a 21 day mice-feeding trial, indicated no adverse effects, suggesting B. amyloliquefaciens LJ1 is non-pathogenic. In vitro assays demonstrated significant inhibitory activity against Penicillium expansum, a major post-harvest pathogen, by suppressing spore germination and germ-tube elongation. These results suggest that B. amyloliquefaciens LJ1 possesses significant biocontrol potential and could be a promising agent for sustainable disease management in Nanguo pear and potentially other crops.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: